USPTO serial 79399250
RUBY
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- —
- Examiner
- BIBB, SCOTT
- Law office
- TMEG LAW OFFICE 109
What this means
These status codes mean the trademark application is abandoned and no longer pending. Common reasons include missing an Office Action response (600), filing without a valid basis (602), express abandonment by the applicant (604), or failure to respond to an examiner's inquiry (618). Revival may be possible in limited circumstances. If abandonment was unintentional, consult counsel about a petition to revive. Otherwise file a new application if protection is still needed.
Need help with RUBY?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Goods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 001 | Proteins for use in science, industry or manufacture; enzymes; polymers; chemical and biochemical preparations and substances used in industry, agriculture or foodstuffs; chemical diagnostic reagents for industrial use; diagnostic reagents for scientific use; chemicals for analytical, diagnostic and immunological purposes and laboratory use; chemicals for use in the manufacture of pharmaceuticals; libraries and collections of the aforementioned chemicals; antibodies for scientific purposes, other than for medical or veterinary use; libraries and collections of antibodies; antibody formats; bispecific antibody formats, therapeutic antibodies; bispecific antibody formats for immuno-oncological applications; bispecific compounds. | ACTIVE | — |
| 005 | Proteins; chemical preparations containing enzymes for medical purposes; chemical preparations containing enzymes for pharmaceutical use; enzymes for medical purposes; diagnostic reagents; antibodies and libraries of antibodies for medical and pharmaceutical purposes; antibody formats, bispecific antibody formats, therapeutic antibodies, bispecific antibody formats and bispecific compounds for medical and pharmaceutical purposes; antibody formats, bispecific antibody formats, therapeutic antibodies, bispecific antibody formats and bispecific compounds for immuno-oncological applications; immuno-oncology preparations for medical and pharmaceutical purposes. | ACTIVE | — |
| 042 | Bio-technology and scientific research services relating to antibodies, proteins, enzymes, antibody formats, bispecific antibody formats, therapeutic antibodies, bispecific compounds, immune-oncology antibody preparations and pharmaceuticals; research, production and development services relating to antibodies, proteins and enzymes; biological and bio-technology analysis services and laboratory services relating to antibodies, proteins, enzymes, antibody formats, bispecific antibody formats, therapeutic antibodies, bispecific compounds, immune-oncology antibody preparations and pharmaceuticals; biochemical research and development in the field of antibodies, protein and enzyme; scientific laboratory services relating to antibodies, protein and enzyme; research, production and development services relating to antibody formats, bispecific antibody formats, therapeutic antibodies, bispecific antibody formats and bispecific compounds; research, development and production of immuno-oncology antibody preparations and pharmaceuticals; information, advisory and consultancy services relating to all of the aforesaid services. | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| May 7, 2026 | FINT | FINAL DECISION TRANSACTION PROCESSED BY IB | — |
| Apr 21, 2026 | FICS | FINAL DISPOSITION NOTICE SENT TO IB | — |
| Apr 21, 2026 | FICR | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | — |
| Dec 18, 2025 | OPNX | NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB | — |
| Dec 3, 2025 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | — |
| Dec 3, 2025 | OPNR | NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB | — |
| Apr 21, 2025 | MAB2 | ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND | The trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time. |
| Apr 21, 2025 | ABN2 | ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE | The trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time. |
| Oct 19, 2024 | RFNT | REFUSAL PROCESSED BY IB | — |
| Oct 2, 2024 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Oct 2, 2024 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Sep 27, 2024 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Sep 26, 2024 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Sep 24, 2024 | DOCK | ASSIGNED TO EXAMINER | — |
| Jul 11, 2024 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Jul 11, 2024 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Jul 4, 2024 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |